cd95 (fas) antibody, anti-human (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
cd95 (fas) antibody, anti-human
Cd95 (Fas) Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 205 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd95/CD95+(FAS)+Antibody%2C+anti-human/custom%40130-124-261%4042323488
Average 93 stars, based on 205 article reviews
Cd95 (Fas) Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 205 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd95/CD95+(FAS)+Antibody%2C+anti-human/custom%40130-124-261%4042323488
Average 93 stars, based on 205 article reviews
cd95 (fas) antibody, anti-human - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Flow Cytometry:Article Title: Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma Article Snippet: .. Flow cytometry TAA-Ts were stained with fluorophore-conjugated antibodies against CD45, CD19, CD3, CD4, CD8, TCRαβ, TCRγδ, Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and Staining:Article Title: Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma Article Snippet: .. Flow cytometry TAA-Ts were stained with fluorophore-conjugated antibodies against CD45, CD19, CD3, CD4, CD8, TCRαβ, TCRγδ, Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and other:Article Title: Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging Article Snippet: CD95 , Article Title: Mycobacterial antigen compositions and methods of use Article Snippet: TABLE 4 Conjugated Antibody Fluorophores and Clones Company Marker Fluorophore Clone BioLegend CD16 FITC 3G8 BioLegend CD127 PE A019D5 Miltenyi CD14 PerCP TUK4 BioLegend CD19 PerCP Cy5.5 HIB19 MIltenyi CD57 PE-Vio770 REA769 BioLegend TCRgd APC B1 BioLegend CD25 Ax700 BC96 BioLegend CD3 APC-Fire750 SK7 BioLegend CD8 BV421 RPA-T8 BioLegend CD4 BV605 DREG-56 BioLegend CD27 FITC O323 BioLegend CD95 PE-Daz594 OKT4 BD CD28 PECy5 CD28.2 (RUO) Miltenyi CD45RO PE-Vio770 REA611 BioLegend CCR7 Ax700 G043H7 BioLegend CD62L BV650 DREG-56 eBioscience CTLA4 FITC 14D3 BioLegend TNFa PE MAb11 BioLegend Perforin PerCP Cy5.5 B-D48 BioLegend CD223 (LAG3) PE-Cy7 11C3C65 BD PD-1 APC MIH4 Invitrogen IFNy Ax700 4S.B3 BioLegend CD366 (TIM3) BV650 F38-2E2 On Day 1, MSTs from healthy and BCG-vaccinated donors were rested overnight with low dose IL-2 (50 U/mL). Activity Assay:Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and Expressing:Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and Derivative Assay:Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and Generated:Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and Concentration Assay:Article Title: Agonistic CD40 antibodies Article Snippet: .. To test the activity of humanized, agonistic anti-CD40 IgG1-LALA antibodies in stimulating costimulatory receptor expression and inflammatory cytokine release by DCs, immature, monocyte derived DCs (iDCs) were generated from three independent donors as described in Examples 5. iDCs were treated with the antibodies at a concentration of 2 μg/ml or CD40L (R&D Systems 6245-CL-050) at 20 μg/ml for 48 h. Stimulated, mature DCs were harvested, stained using fluorophore-labelled antibodies against HLA-DR, CD86, CD80, CD83, CD54 and |